These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9652693)

  • 1. Chimerism in scleroderma.
    Aractingi S; Dausset J; Carosella ED
    Lancet; 1998 Jun; 351(9119):1886; author reply 1887. PubMed ID: 9652693
    [No Abstract]   [Full Text] [Related]  

  • 2. Chimerism in scleroderma.
    Mullinax F
    Lancet; 1998 Jun; 351(9119):1886; author reply 1887. PubMed ID: 9652692
    [No Abstract]   [Full Text] [Related]  

  • 3. Similarity of scleroderma-like skin lesions in allogeneic and syngeneic bone marrow transplantation models.
    Bos GM; Majoor GD; Slaaf DW; van de Gaar MJ; Weijmer-van Velzen JS; van Breda Vriesman PJ
    Transplant Proc; 1989 Apr; 21(2):3262-3. PubMed ID: 2652812
    [No Abstract]   [Full Text] [Related]  

  • 4. Microchimerism and the pathogenesis of systemic sclerosis.
    Nelson JL
    Curr Opin Rheumatol; 1998 Nov; 10(6):564-71. PubMed ID: 9812217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microchimerism and autoimmune disease.
    Nelson JL
    N Engl J Med; 1998 Apr; 338(17):1224-5. PubMed ID: 9554866
    [No Abstract]   [Full Text] [Related]  

  • 6. Graft-versus-host reactions and autoimmune disease.
    Lancet; 1978 Mar; 1(8062):480-1. PubMed ID: 76026
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion.
    Skert C; Patriarca F; Zaja F; Tomadini V; Fanin R
    Bone Marrow Transplant; 2005 Mar; 35(5):523-4. PubMed ID: 15654352
    [No Abstract]   [Full Text] [Related]  

  • 8. Microchimerism: implications for autoimmune disease.
    Nelson JL
    Lupus; 1999; 8(5):370-4. PubMed ID: 10455515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
    Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
    Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatomyositis developed in a recipient of allogeneic BMT; the differentiation of chronic GVHD and autoimmune disease.
    Sakamoto K; Imamura T; Niwa F; Komori S; Ishihara Y; Shiga K; Ito M; Hosoi H
    Bone Marrow Transplant; 2012 Apr; 47(4):603-4. PubMed ID: 21666739
    [No Abstract]   [Full Text] [Related]  

  • 11. Animal models of scleroderma.
    Lakos G; Takagawa S; Varga J
    Methods Mol Med; 2004; 102():377-93. PubMed ID: 15286396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is graft-versus-host disease a reliable model for scleroderma?
    Mekori YA; Claman HN
    Ric Clin Lab; 1986; 16(4):509-13. PubMed ID: 3576048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma].
    Speranskiĭ AI; Riazantseva TA; Guseva NG; Melkumova KL; Ivanova SM
    Revmatologiia (Mosk); 1990; (3):11-4. PubMed ID: 2098888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma: chimerism, the blind man, and the scientist.
    Welsh K
    Lancet; 1998 Feb; 351(9102):540-1. PubMed ID: 9492769
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.
    Sternberg EM
    Surv Immunol Res; 1985; 4(1):69-80. PubMed ID: 3890057
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is scleroderma an allo-immune disease?].
    Cosnes A; Cabane J; Humbert P; Emmerich J; Bagot M; Maquart FX; Aractingi S
    Ann Dermatol Venereol; 1999 Mar; 126(3):291-4. PubMed ID: 10394448
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo demonstration of microvascular pathology by intravital microscopy in experimental chronic graft-versus-host disease: analogy with scleroderma.
    Bos G; Majoor G; Slaaf D; Reneman R; van Breda Vriesman P
    J Rheumatol; 1988 Sep; 15(9):1339-45. PubMed ID: 3058970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endothelium: its role in scleroderma.
    Pearson JD
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):866-71. PubMed ID: 1750799
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental models of systemic scleroderma].
    Serakovski S; Kukhazh E; Bernatska K
    Revmatologiia (Mosk); 1989; (3):36-46. PubMed ID: 2692123
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic cyclosporine-induced autoimmune disease in the rat: a new experimental model for scleroderma.
    Bos GM; Majoor GD; Willighagen RG; van Breda Vriesman PJ
    J Invest Dermatol; 1989 Nov; 93(5):610-5. PubMed ID: 2794549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.